1. What concerns regarding CE and the IOM’s study should be brought to the attention of the committee?

Linda Coogle, North American Association of Medical Education and Communication Companies Cathryn Clary, Pfizer, Inc.

4:00-4:15

PM Q&A

4:15 PM

Perspectives from Users of Continuing Education

  1. What is the current importance of CE to your daily work?

  2. How could CE be changed to make it more useful to you and a more integral part of your practice?

  3. What concerns regarding CE and the IOM’s study should be brought to the attention of the committee?

Medicine—Michael Moore, Danville Regional Medical Center

Nursing—Patricia Lane, National Black Nurses Association and Inova Fairfax Hospital

Pharmacy—Rebecca Snead, National Alliance of State Pharmacy Associations

4:40-5:00 PM

Q&A

5:00 PM

Continuing Education for Improved Patient Outcomes

  1. What is the current importance of CE for patient well-being?

  2. How could CE be improved to benefit patients?

  3. What concerns regarding CE and the IOM’s study should be brought to the attention of the committee?

John T. James, Patient Safety Advocate

David Swankin, Citizen Advocacy Center

5:15-5:30

PM Q&A

5:30 PM

ADJOURN



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement